Working… Menu
Trial record 1 of 1 for:    nct02193282
Previous Study | Return to List | Next Study

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02193282
Recruitment Status : Active, not recruiting
First Posted : July 17, 2014
Last Update Posted : March 19, 2021
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 4, 2021
Study Completion Date : No date given